Health and Plant Protein Group Limited Logo

Health and Plant Protein Group Limited

HPP.AX

(1.8)
Stock Price

0,04 AUD

-119.29% ROA

-117.66% ROE

-0.63x PER

Market Cap.

5.158.471,00 AUD

0% DER

0% Yield

-39230.95% NPM

Health and Plant Protein Group Limited Stock Analysis

Health and Plant Protein Group Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Health and Plant Protein Group Limited Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (0.21x), the stock offers substantial upside potential at a bargain price.

2 ROE

The stock's ROE falls within an average range (2.89%), demonstrating satisfactory profitability and efficiency in utilizing shareholders' equity.

3 ROA

The stock's ROA (1.2%) shows that it's doing a pretty good job at making money from its assets, making it a solid choice to invest and earn steady profits.

4 DER

The stock maintains a fair debt to equity ratio (85%), indicating a reasonable balance between the money it owes and the ownership it possesses.

5 Graham Number

Based on the Graham number, this company's stock price appears to be lower than its intrinsic value, signaling a potentially favorable investment choice.

6 Buffet Intrinsic Value

The company's stock seems undervalued (22) by Warren Buffett's formula, indicating a promising investment opportunity as its intrinsic value exceeds the market price.

7 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

8 Net Profit Growth

This company's net profit has remained flat over the past five years, suggesting a lack of growth and making it a less attractive investment opportunity.

9 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

10 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

11 Dividend

The company's decision to withhold dividends for three years raises questions about its ability to generate consistent returns.

Health and Plant Protein Group Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Health and Plant Protein Group Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Sell
4 Stoch RSI Hold

Health and Plant Protein Group Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Health and Plant Protein Group Limited Revenue
Year Revenue Growth
1990 13.400.000
1991 15.700.000 14.65%
1992 14.400.000 -9.03%
1993 16.408.000 12.24%
1994 15.592.000 -5.23%
1995 17.913.000 12.96%
1996 17.612.000 -1.71%
1997 18.184.000 3.15%
1998 0 0%
1999 25.285.000 100%
2000 0 0%
2001 29.289.000 100%
2002 30.166.000 2.91%
2003 30.166.000 0%
2004 30.398.000 0.76%
2005 35.471.000 14.3%
2006 45.954.000 22.81%
2007 47.977.000 4.22%
2008 50.465.000 4.93%
2009 72.645.000 30.53%
2010 90.392.000 19.63%
2011 86.220.000 -4.84%
2012 78.891.000 -9.29%
2013 76.612.000 -2.97%
2014 63.160.000 -21.3%
2015 70.720.000 10.69%
2016 78.473.000 9.88%
2017 68.587.000 -14.41%
2018 56.413.000 -21.58%
2019 71.802.000 21.43%
2020 42.115.000 -70.49%
2021 36.230.000 -16.24%
2022 42.250.000 14.25%
2023 0 0%
2024 50.000 100%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Health and Plant Protein Group Limited Research and Development Expenses
Year Research and Development Expenses Growth
1990 0
1991 0 0%
1992 0 0%
1993 0 0%
1994 173.000 100%
1995 37.000 -367.57%
1996 82.000 54.88%
1997 39.000 -110.26%
1998 0 0%
1999 136.000 100%
2000 0 0%
2001 127.000 100%
2002 0 0%
2003 97.000 100%
2004 17.000 -470.59%
2005 0 0%
2006 33.000 100%
2007 35.000 5.71%
2008 18.000 -94.44%
2009 69.000 73.91%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Health and Plant Protein Group Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
1990 0
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 1.099.000 100%
2004 1.451.000 24.26%
2005 1.392.000 -4.24%
2006 2.977.000 53.24%
2007 2.989.000 0.4%
2008 2.798.000 -6.83%
2009 5.128.000 45.44%
2010 6.262.000 18.11%
2011 8.088.000 22.58%
2012 6.370.000 -26.97%
2013 6.468.000 1.52%
2014 5.714.000 -13.2%
2015 6.700.000 14.72%
2016 6.895.000 2.83%
2017 6.579.000 -4.8%
2018 6.670.000 1.36%
2019 8.375.000 20.36%
2020 5.284.000 -58.5%
2021 6.844.000 22.79%
2022 5.838.000 -17.23%
2023 4.670.000 -25.01%
2024 1.304.000 -258.13%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Health and Plant Protein Group Limited EBITDA
Year EBITDA Growth
1990 1.782.000
1991 2.234.000 20.23%
1992 2.353.000 5.06%
1993 2.507.000 6.14%
1994 2.458.000 -1.99%
1995 2.301.000 -6.82%
1996 1.348.000 -70.7%
1997 2.147.000 37.21%
1998 1.776.000 -20.89%
1999 1.134.000 -56.61%
2000 2.044.000 44.52%
2001 -1.162.000 275.9%
2002 4.707.000 124.69%
2003 2.885.000 -63.15%
2004 2.510.000 -14.94%
2005 2.429.000 -3.33%
2006 2.999.000 19.01%
2007 2.462.000 -21.81%
2008 3.706.000 33.57%
2009 7.575.000 51.08%
2010 -190.000 4086.84%
2011 173.000 209.83%
2012 5.814.000 97.02%
2013 6.871.000 15.38%
2014 291.000 -2261.17%
2015 5.588.000 94.79%
2016 -1.361.000 510.58%
2017 -1.510.000 9.87%
2018 -4.404.000 65.71%
2019 5.352.000 182.29%
2020 1.535.000 -248.66%
2021 -10.283.000 114.93%
2022 3.582.000 387.07%
2023 -4.539.000 178.92%
2024 -2.608.000 -74.04%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Health and Plant Protein Group Limited Gross Profit
Year Gross Profit Growth
1990 13.400.000
1991 15.700.000 14.65%
1992 14.400.000 -9.03%
1993 16.408.000 12.24%
1994 15.592.000 -5.23%
1995 17.913.000 12.96%
1996 17.612.000 -1.71%
1997 18.184.000 3.15%
1998 0 0%
1999 25.285.000 100%
2000 0 0%
2001 29.289.000 100%
2002 10.543.000 -177.81%
2003 10.153.000 -3.84%
2004 10.046.000 -1.07%
2005 10.519.000 4.5%
2006 12.876.000 18.31%
2007 12.585.000 -2.31%
2008 13.467.000 6.55%
2009 18.028.000 25.3%
2010 17.417.000 -3.51%
2011 17.493.000 0.43%
2012 21.006.000 16.72%
2013 20.392.000 -3.01%
2014 8.849.000 -130.44%
2015 13.193.000 32.93%
2016 10.957.000 -20.41%
2017 5.238.000 -109.18%
2018 3.455.000 -51.61%
2019 20.347.000 83.02%
2020 9.884.000 -105.86%
2021 1.387.000 -612.62%
2022 11.789.000 88.23%
2023 -131.000 9099.24%
2024 50.000 362%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Health and Plant Protein Group Limited Net Profit
Year Net Profit Growth
1990 335.000
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 1.190.000 100%
1998 0 0%
1999 719.000 100%
2000 1.095.000 34.34%
2001 -1.611.000 167.97%
2002 1.284.000 225.47%
2003 770.000 -66.75%
2004 504.000 -52.78%
2005 -131.000 484.73%
2006 536.000 124.44%
2007 -165.000 424.85%
2008 671.000 124.59%
2009 2.006.000 66.55%
2010 -1.715.000 216.97%
2011 -1.967.000 12.81%
2012 1.541.000 227.64%
2013 1.840.000 16.25%
2014 -1.493.000 223.24%
2015 290.000 614.83%
2016 -6.626.000 104.38%
2017 -8.971.000 26.14%
2018 -16.720.000 46.35%
2019 -235.000 -7014.89%
2020 -7.566.000 96.89%
2021 -10.112.000 25.18%
2022 665.000 1620.6%
2023 -9.997.000 106.65%
2024 -2.992.000 -234.12%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Health and Plant Protein Group Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1990 0
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Health and Plant Protein Group Limited Free Cashflow
Year Free Cashflow Growth
1990 0
1991 0 0%
1992 -326.000 100%
1993 -894.000 63.53%
1994 -297.000 -201.01%
1995 1.372.000 121.65%
1996 276.000 -397.1%
1997 1.252.000 77.96%
1998 -874.000 243.25%
1999 285.000 406.67%
2000 -3.200.000 108.91%
2001 -1.024.000 -212.5%
2002 1.487.000 168.86%
2003 699.000 -112.73%
2004 887.000 21.2%
2005 -3.249.000 127.3%
2006 -1.988.000 -63.43%
2007 109.000 1923.85%
2008 -7.485.000 101.46%
2009 -2.707.000 -176.51%
2010 -4.039.000 32.98%
2011 3.483.000 215.96%
2012 -1.830.000 290.33%
2013 430.000 525.58%
2014 -1.282.000 133.54%
2015 -7.065.000 81.85%
2016 -3.528.000 -100.26%
2017 -3.972.000 11.18%
2018 -1.721.000 -130.8%
2019 -7.470.000 76.96%
2020 -292.000 -2458.22%
2021 -3.544.000 91.76%
2022 576.000 715.28%
2023 -8.730.000 106.6%
2024 -893.000 -877.6%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Health and Plant Protein Group Limited Operating Cashflow
Year Operating Cashflow Growth
1990 0
1991 0 0%
1992 331.000 100%
1993 186.000 -77.96%
1994 602.000 69.1%
1995 1.991.000 69.76%
1996 1.916.000 -3.91%
1997 1.470.000 -30.34%
1998 0 0%
1999 704.000 100%
2000 0 0%
2001 128.000 100%
2002 2.271.000 94.36%
2003 2.225.000 -2.07%
2004 3.336.000 33.3%
2005 1.010.000 -230.3%
2006 840.000 -20.24%
2007 2.193.000 61.7%
2008 -1.388.000 258%
2009 963.000 244.13%
2010 -742.000 229.78%
2011 5.035.000 114.74%
2012 0 0%
2013 2.517.000 100%
2014 462.000 -444.81%
2015 145.000 -218.62%
2016 -2.404.000 106.03%
2017 -3.289.000 26.91%
2018 -840.000 -291.55%
2019 -7.134.000 88.23%
2020 860.000 929.53%
2021 -2.619.000 132.84%
2022 1.398.000 287.34%
2023 -8.730.000 116.01%
2024 -893.000 -877.6%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Health and Plant Protein Group Limited Capital Expenditure
Year Capital Expenditure Growth
1990 0
1991 0 0%
1992 657.000 100%
1993 1.080.000 39.17%
1994 899.000 -20.13%
1995 619.000 -45.23%
1996 1.640.000 62.26%
1997 218.000 -652.29%
1998 874.000 75.06%
1999 419.000 -108.59%
2000 3.200.000 86.91%
2001 1.152.000 -177.78%
2002 784.000 -46.94%
2003 1.526.000 48.62%
2004 2.449.000 37.69%
2005 4.259.000 42.5%
2006 2.828.000 -50.6%
2007 2.084.000 -35.7%
2008 6.097.000 65.82%
2009 3.670.000 -66.13%
2010 3.297.000 -11.31%
2011 1.552.000 -112.44%
2012 1.830.000 15.19%
2013 2.087.000 12.31%
2014 1.744.000 -19.67%
2015 7.210.000 75.81%
2016 1.124.000 -541.46%
2017 683.000 -64.57%
2018 881.000 22.47%
2019 336.000 -162.2%
2020 1.152.000 70.83%
2021 925.000 -24.54%
2022 822.000 -12.53%
2023 0 0%
2024 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Health and Plant Protein Group Limited Equity
Year Equity Growth
1990 9.408.000
1991 9.841.000 4.4%
1992 10.677.000 7.83%
1993 11.112.000 3.91%
1994 13.305.000 16.48%
1995 13.973.000 4.78%
1996 14.496.000 3.61%
1997 14.753.000 1.74%
1998 15.656.000 5.77%
1999 15.822.000 1.05%
2000 17.778.000 11%
2001 16.167.000 -9.96%
2002 16.823.000 3.9%
2003 17.763.000 5.29%
2004 18.129.000 2.02%
2005 21.442.000 15.45%
2006 22.530.000 4.83%
2007 26.865.000 16.14%
2008 29.358.000 8.49%
2009 35.915.000 18.26%
2010 32.501.000 -10.5%
2011 28.333.000 -14.71%
2012 34.333.000 17.48%
2013 34.483.000 0.43%
2014 39.520.000 12.75%
2015 43.090.000 8.28%
2016 40.127.000 -7.38%
2017 41.862.000 4.14%
2018 32.025.000 -30.72%
2019 36.259.000 11.68%
2020 26.389.000 -37.4%
2021 20.925.000 -26.11%
2022 25.043.000 16.44%
2023 7.287.000 -243.67%
2024 6.717.000 -8.49%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Health and Plant Protein Group Limited Assets
Year Assets Growth
1990 12.276.000
1991 13.912.000 11.76%
1992 14.593.000 4.67%
1993 17.512.000 16.67%
1994 20.178.000 13.21%
1995 19.591.000 -3%
1996 20.377.000 3.86%
1997 20.683.000 1.48%
1998 21.369.000 3.21%
1999 22.534.000 5.17%
2000 28.303.000 20.38%
2001 28.271.000 -0.11%
2002 28.512.000 0.85%
2003 28.479.000 -0.12%
2004 28.939.000 1.59%
2005 37.231.000 22.27%
2006 43.755.000 14.91%
2007 49.988.000 12.47%
2008 64.477.000 22.47%
2009 85.948.000 24.98%
2010 80.187.000 -7.18%
2011 71.617.000 -11.97%
2012 69.128.000 -3.6%
2013 68.898.000 -0.33%
2014 78.678.000 12.43%
2015 85.614.000 8.1%
2016 92.787.000 7.73%
2017 77.247.000 -20.12%
2018 67.672.000 -14.15%
2019 81.553.000 17.02%
2020 73.598.000 -10.81%
2021 49.946.000 -47.36%
2022 56.138.000 11.03%
2023 8.557.000 -556.05%
2024 6.906.000 -23.91%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Health and Plant Protein Group Limited Liabilities
Year Liabilities Growth
1990 2.868.000
1991 4.071.000 29.55%
1992 3.916.000 -3.96%
1993 6.400.000 38.81%
1994 6.873.000 6.88%
1995 5.618.000 -22.34%
1996 5.881.000 4.47%
1997 5.930.000 0.83%
1998 5.713.000 -3.8%
1999 6.712.000 14.88%
2000 10.525.000 36.23%
2001 12.104.000 13.05%
2002 11.689.000 -3.55%
2003 10.716.000 -9.08%
2004 10.810.000 0.87%
2005 14.569.000 25.8%
2006 20.107.000 27.54%
2007 22.316.000 9.9%
2008 34.309.000 34.96%
2009 50.033.000 31.43%
2010 48.680.000 -2.78%
2011 43.284.000 -12.47%
2012 34.795.000 -24.4%
2013 34.415.000 -1.1%
2014 39.158.000 12.11%
2015 42.524.000 7.92%
2016 52.660.000 19.25%
2017 35.385.000 -48.82%
2018 35.647.000 0.73%
2019 45.294.000 21.3%
2020 47.209.000 4.06%
2021 29.021.000 -62.67%
2022 31.095.000 6.67%
2023 1.270.000 -2348.43%
2024 189.000 -571.96%

Health and Plant Protein Group Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
-0.07
Price to Earning Ratio
-0.63x
Price To Sales Ratio
245.64x
POCF Ratio
-0.55
PFCF Ratio
-0.56
Price to Book Ratio
0.77
EV to Sales
141.07
EV Over EBITDA
-0.52
EV to Operating CashFlow
-0.32
EV to FreeCashFlow
-0.32
Earnings Yield
-1.6
FreeCashFlow Yield
-1.77
Market Cap
0,01 Bil.
Enterprise Value
0,00 Bil.
Graham Number
0.29
Graham NetNet
0.04

Income Statement Metrics

Net Income per Share
-0.07
Income Quality
0.85
ROE
-1.18
Return On Assets
-1.19
Return On Capital Employed
-0.99
Net Income per EBT
1.2
EBT Per Ebit
1.03
Ebit per Revenue
-315.67
Effective Tax Rate
-0.16

Margins

Sales, General, & Administrative to Revenue
229.29
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
8.48
Gross Profit Margin
-4.29
Operating Profit Margin
-315.67
Pretax Profit Margin
-326.5
Net Profit Margin
-392.31

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.08
Free CashFlow per Share
-0.07
Capex to Operating CashFlow
-0.02
Capex to Revenue
7.71
Capex to Depreciation
0.23
Return on Invested Capital
-1.15
Return on Tangible Assets
-1.19
Days Sales Outstanding
81221.19
Days Payables Outstanding
559.01
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
0.65
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
0,02
Book Value per Share
0,05
Tangible Book Value per Share
0.05
Shareholders Equity per Share
0.05
Interest Debt per Share
0.02
Debt to Equity
0
Debt to Assets
0
Net Debt to EBITDA
0.38
Current Ratio
36.54
Tangible Asset Value
0,01 Bil.
Net Current Asset Value
0,01 Bil.
Invested Capital
0
Working Capital
0,01 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Health and Plant Protein Group Limited Dividends
Year Dividends Growth
1991 0
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2006 0 0%
2008 0 0%
2012 0 0%
2013 0 0%

Health and Plant Protein Group Limited Profile

About Health and Plant Protein Group Limited

Health and Plant Protein Group Limited engages in the processing, production, and marketing of macadamia products to wholesale and retail customers in North America. It offers its products under the Royal Hawaiian Orchards and MacFarms brands. The company was formerly known as Buderim Group Limited and changed its name to Health and Plant Protein Group Limited in December 2020. Health and Plant Protein Group Limited was founded in 1941 and is headquartered in Milton, Australia.

CEO
Mr. Kuk Tse Yeuk BBus, CA, Gra
Employee
1
Address
159 Coronation Drive
Milton, 4064

Health and Plant Protein Group Limited Executives & BODs

Health and Plant Protein Group Limited Executives & BODs
# Name Age
1 Deane Conway
Company Secretary
70
2 Mr. Kuk Tse Yeuk BBus, CA, Grad.Dip., JP (Qual), LLB
Executive Chairman
70

Health and Plant Protein Group Limited Competitors